Skip to main content

    Creating a
    Healthier World
    for Everyone


    Creating a
    Healthier World
    for Everyone

About Us

This is Pamoja
Pamoja means "together". This is the vision of Hans and Ashok: Creating mono- and combination therapies together with world class universities and clinical researchers to benefit people together; regardless of their colour, class or social standing. In short, repurposing drugs to target deadly and neglected diseases in the most cost-effective way.

Product Portfolio

Actively Repur­posing
Our current product portfolio consists of:
  • 25, 50 and 100 mg artesunate tablets and matching placebos with IMPD and approved for use in clinical trials in France, Gabon and Malaysia
  • 60 mg per vial artesunate powder for solution for intramuscular or intravenous use
  • 120 mg/ml, 5 ml per vial pyronaridine parenteral solution for intramuscular or intravenous use
Combinations with other pharmaceutical actives can be developed and prepared on request.
  • Our Team

    Together for a
    better tomorrow.

    The team has long-standing experience with artesunate, having been actively involved in the development and production of artemisinin combination therapies and bringing them to the private market in Africa and South East-Asia for over 20 years. Its main product is available under the brand name Co-Arinate and is distributed by Dafra Pharma from Belgium all over Africa.

Hans Platteeuw

Mr. Platteeuw holds a master’s degree in Chemistry from the University of Nijmegen, The Netherlands. He started his career at Synthon BV as Project Manager of pharmaceutical product development and later became the company’s Head of Galenical R&D. In 2004 he moved to Dafra Pharma, a private company specialized in antimalarial medication where he acted as Director R&D and was instrumental for the launch of Co-Arinate. In 2005, he started Avivia BV, a company specialized in pharmaceutical product development with a specific expertise in the development and intellectual property protection of specialty generics products.

Ashok Krishna

Non-Executive Director
After schooling in Tanzania, India and the UK, Mr. Krishna completed BSc and MSc degrees in Electrical Engineering and Operational Research at Imperial College London. During his PhD, he then was headhunted to work as a strategy analyst and later project manager for Lucas Industries in London. Subsequently, he moved to Germany and ran various family businesses in branches as diverse as textiles and paper coatings. After selling the largest German business in 2020, he explored more philanthropic enterprises, and Pamoja b.v. was founded in 2024.

Contact Us

Reach Out. Connect. Thrive.
Looking forward to hearing from you with opportunities to work together!